Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.

Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, T├Ârn C, Persson B, Lernmark A.

J Clin Endocrinol Metab. 2000 Dec;85(12):4671-9.

PMID:
11134126
2.

Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias.

Mitoma H, Manto M, Hampe CS.

J Immunol Res. 2017;2017:2913297. doi: 10.1155/2017/2913297. Epub 2017 Mar 12. Review.

3.

GAD65 neurological autoimmunity.

McKeon A, Tracy JA.

Muscle Nerve. 2017 Jul;56(1):15-27. doi: 10.1002/mus.25565. Epub 2017 Apr 11. Review.

PMID:
28063151
4.

Diamyd, an alum-formulated recombinant human GAD65 for the prevention of autoimmune diabetes.

Hinke SA.

Curr Opin Mol Ther. 2008 Oct;10(5):516-25. Review.

PMID:
18830927

Supplemental Content

Support Center